Evidence-Based Medicine Guidelines
Vitamin K antagonists or low-molecular weight heparin for venous thromboembolism
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Vitamin K Antagonists or Low-molecular Weight Heparin for Venous Thromboembolism." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/456257/all/__________Vitamin_K_antagonists_or_low_molecular_weight_heparin_for_venous_thromboembolism______.
Vitamin K antagonists or low-molecular weight heparin for venous thromboembolism. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/456257/all/__________Vitamin_K_antagonists_or_low_molecular_weight_heparin_for_venous_thromboembolism______. Accessed March 27, 2025.
Vitamin K antagonists or low-molecular weight heparin for venous thromboembolism. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/456257/all/__________Vitamin_K_antagonists_or_low_molecular_weight_heparin_for_venous_thromboembolism______
Vitamin K Antagonists or Low-molecular Weight Heparin for Venous Thromboembolism [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 March 27]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/456257/all/__________Vitamin_K_antagonists_or_low_molecular_weight_heparin_for_venous_thromboembolism______.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Vitamin K antagonists or low-molecular weight heparin for venous thromboembolism
ID - 456257
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/456257/all/__________Vitamin_K_antagonists_or_low_molecular_weight_heparin_for_venous_thromboembolism______
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
